Marie K. Mankowski

837 total citations
23 papers, 604 citations indexed

About

Marie K. Mankowski is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Marie K. Mankowski has authored 23 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 15 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Marie K. Mankowski's work include HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (6 papers). Marie K. Mankowski is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (6 papers). Marie K. Mankowski collaborates with scholars based in United States, Russia and Switzerland. Marie K. Mankowski's co-authors include Roger G. Ptak, Beth A. Snyder, James E. Cummins, Simon Cocklin, Robert W. Buckheit, Jimmy P. Xu, Abdül Waheed, Carl P. Schaffner, Carol Lackman-Smith and Sherimay D. Ablan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Marie K. Mankowski

22 papers receiving 586 citations

Peers

Countries citing papers authored by Marie K. Mankowski

Since Specialization

Citations

This map shows the geographic impact of Marie K. Mankowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie K. Mankowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie K. Mankowski more than expected).

Fields of papers citing papers by Marie K. Mankowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie K. Mankowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie K. Mankowski. The network helps show where Marie K. Mankowski may publish in the future.

Co-authorship network of co-authors of Marie K. Mankowski

This figure shows the co-authorship network connecting the top 25 collaborators of Marie K. Mankowski. A scholar is included among the top collaborators of Marie K. Mankowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie K. Mankowski. Marie K. Mankowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties 2024 ·PLoS Pathogens ·Zheng Zhou, Jia Guo, (unknown), Sameer K. Tiwari, (unknown), Yang Han, Vincent C. Bond, Ming Huang, Marie K. Mankowski, Beth A. Snyder, (unknown), Savita K. Sharma, Dennis C. Liotta, (unknown), Lawrence J. Wilson, Yuntao Wu	2
2	An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation 2016 ·Antiviral Research ·Ryan P. Bennett, (unknown), (unknown), Roger G. Ptak, Marie K. Mankowski, Tracy L. Hartman, Robert W. Buckheit, Beth A. Snyder, Jason D. Salter, Guillermo A. Morales, Harold C. Smith	28
3	Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1 2015 ·Virology ·(unknown), Ann M. Sheehy, (unknown), Vikas Misra, Marie K. Mankowski, Lynn Rasmussen, E. Lucile White, Roger G. Ptak, Dana Gabuzda	13
4	Identification of a Novel HIV-1 Inhibitor Targeting Vif-dependent Degradation of Human APOBEC3G Protein 2015 ·Journal of Biological Chemistry ·(unknown), Ann M. Sheehy, (unknown), Andrew J. Brazier, Vikas Misra, Kottampatty S. Rajendran, Sara J. Buhrlage, Marie K. Mankowski, Lynn Rasmussen, E. Lucile White, Roger G. Ptak, Dana Gabuzda	35
5	Structure–Activity Relationship Studies of Indole-Based Compounds as Small Molecule HIV-1 Fusion Inhibitors Targeting Glycoprotein 41 2014 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Hardeep Kaur, Beth A. Snyder, Marie K. Mankowski, (unknown), Roger G. Ptak, Miriam Gochin	27
6	Discovery and optimization of novel small-molecule HIV-1 entry inhibitors using field-based virtual screening and bioisosteric replacement 2014 ·Bioorganic & Medicinal Chemistry Letters ·Marina Tuyishime, (unknown), Amy M. Princiotto, Marie K. Mankowski, (unknown), Henry‐Georges Lombart, (unknown), (unknown), Kuang Liang, Jingjing Ji, Roger G. Ptak, Navid Madani, Simon Cocklin	24
7	Abasic Phosphorothioate Oligomers Inhibit HIV-1 Reverse Transcription and Block Virus Transmission across Polarized Ectocervical Organ Cultures 2014 ·Antimicrobial Agents and Chemotherapy ·Joseph A. Fraietta, Yvonne M. Mueller, (unknown), Deena Ratner, Alina C. Boesteanu, Aidan S. Hancock, Carol Lackman-Smith, Isaac Zentner, Irwin Chaiken, Suhman Chung, Stuart F. J. LeGrice, Beth A. Snyder, Marie K. Mankowski, (unknown), Jennifer L. Hope, Phalguni Gupta, Sharon Anderson, Brian Wigdahl, Peter D. Katsikis	0
8	A novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5′-diphospho-glucuronosyltransferase metabolism profile 2013 ·Antiviral Research ·Maurice Okello, (unknown), (unknown), Marie K. Mankowski, (unknown), Jiayi Wei, (unknown), Roger G. Ptak, Vasu Nair	4
9	Identification of a Small‐Molecule Inhibitor of HIV‐1 Assembly that Targets the Phosphatidylinositol (4,5)‐bisphosphate Binding Site of the HIV‐1 Matrix Protein 2013 ·ChemMedChem ·Isaac Zentner, Luz‐Jeannette Sierra, (unknown), (unknown), Marie K. Mankowski, (unknown), П. О. Федичев, Roger G. Ptak, Julio Martín‐García, Simon Cocklin	34
10	Evaluation of PD 404,182 as an Anti-HIV and Anti-Herpes Simplex Virus Microbicide 2013 ·Antimicrobial Agents and Chemotherapy ·(unknown), Michael Bobardt, Bernard J. Moncla, Marie K. Mankowski, Roger G. Ptak, Philippe Gallay, Zhilei Chen	13
11	Discovery of a small-molecule antiviral targeting the HIV-1 matrix protein 2012 ·Bioorganic & Medicinal Chemistry Letters ·Isaac Zentner, Luz‐Jeannette Sierra, (unknown), (unknown), П. О. Федичев, Marie K. Mankowski, Roger G. Ptak, Julio Martín‐García, Simon Cocklin	24
12	Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry 2011 ·Journal of Biological Chemistry ·Bo Zhao, Marie K. Mankowski, Beth A. Snyder, Roger G. Ptak, (unknown)	24
13	In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor 2010 ·Antiviral Research ·Hassan Javanbakht, Roger G. Ptak, Eric P. F. Chow, (unknown), (unknown), Marie K. Mankowski, (unknown), (unknown), (unknown), Julie Q. Hang, (unknown), (unknown), Amber M. Paul, N. Cammack, Klaus Klumpp, Gabrielle Heilek	7
14	Safety and anti-HIV assessments of natural vaginal cleansing products in an established topical microbicides in vitro testing algorithm 2010 ·AIDS Research and Therapy ·Carol Lackman-Smith, Beth A. Snyder, (unknown), (unknown), Marie K. Mankowski, (unknown), (unknown), Nicola Richardson‐Harman, James E. Cummins, Brigitte E. Sanders-Beer	10
15	Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41 2010 ·Antimicrobial Agents and Chemotherapy ·Ioannis Kagiampakis, (unknown), Marie K. Mankowski, Beth A. Snyder, Roger G. Ptak, (unknown), (unknown)	28
16	Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor 2008 ·Journal of Biological Chemistry ·Cheryl A. Stoddart, (unknown), Sofiya A. Galkina, Karen Thibaudeau, (unknown), Nathalie Bousquet-Gagnon, Martin Robitaille, (unknown), Véronique Paradis, (unknown), Alexandra R. Lobach, Marie-Ève Rivard, Roger G. Ptak, Marie K. Mankowski, Dominique Bridon, Omar Quraishi	53
17	Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: Possible role of the prolonged half-life of the immunogen 2008 ·Vaccine ·Mei-Yun Zhang, Yanping Wang, Marie K. Mankowski, Roger G. Ptak, Dimiter S. Dimitrov	31
18	Development of a Comprehensive Human Immunodeficiency Virus Type 1 Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides 2008 ·Antimicrobial Agents and Chemotherapy ·Carol Lackman-Smith, (unknown), (unknown), Marie K. Mankowski, Beth A. Snyder, G.R. Lewis, Jeremy Ra Paull, Albert T. Profy, Roger G. Ptak, Robert W. Buckheit, Karen Watson, James E. Cummins, Brigitte E. Sanders-Beer	92
19	Inhibition of HIV-1 Replication by Amphotericin B Methyl Ester 2006 ·Journal of Biological Chemistry ·Abdül Waheed, Sherimay D. Ablan, Marie K. Mankowski, James E. Cummins, Roger G. Ptak, Carl P. Schaffner, Eric O. Freed	53
20	Critical Design Features of Phenyl Carboxylate-Containing Polymer Microbicides 2006 ·Antimicrobial Agents and Chemotherapy ·Robert F. Rando, Sakaé Obara, (unknown), Marie K. Mankowski, Shendra R. Miller, Mary Ferguson, Fred C. Krebs, Brian Wigdahl, Mohamed E. Labib, Hiroyasu Kokubo	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact